2025 annual financial data
Rhythm Pharmaceuticals 2025 Operating margin
Rhythm Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -101.19%.
Operating income was -192,016,000 USD and net income was -196,539,000 USD.
Operating cash flow was -115,675,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 189,757,000 USD
- Operating income
- -192,016,000 USD
- Net income
- -196,539,000 USD
- Operating cash flow
- -115,675,000 USD